{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-000406","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2022-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.387991+00:00","generated_at":"2026-06-27T20:41:58.391459+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Anebulo Pharmaceuticals names Simon Allen CEO effective Feb 1, 2022; Dr. Schneeberger resigns","bullets":["Simon Allen appointed CEO and director, effective Feb 1, 2022; succeeds Daniel Schneeberger.","Dr. Schneeberger's resignation not due to any disagreement with company operations or policies.","Allen receives $450k base salary; stock options for 625k shares at $6.21 vesting quarterly over 4 years.","Allen eligible for $1.5M cash bonus if company sold for ≥$500M with Board approval.","Severance of 9 months base salary plus COBRA reimbursement for 12 months if terminated without cause."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-000406","json":"https://secwatch.observer/filing/0001493152-22-000406.json","markdown":"https://secwatch.observer/filing/0001493152-22-000406.md","text":"https://secwatch.observer/filing/0001493152-22-000406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222000406/0001493152-22-000406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222000406/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:41:58.391459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d078f6a99","claim":"Simon Allen was elected as Member of the Board of Directors at Anebulo Pharmaceuticals, Inc..","evidence_excerpt":"On January 3, 2022, Simon Allen was appointed to be our Chief Executive Officer and elected a member of our Board of Directors, both to be effective on February 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222000406/0001493152-22-000406-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"},{"claim_id":"110212d7d5","claim":"Daniel Schneeberger resigned as Chief Executive Officer at Anebulo Pharmaceuticals, Inc..","evidence_excerpt":"Daniel Schneeberger, M.D. resigned such positions in order to bring in Mr. Allen.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222000406/0001493152-22-000406-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"eca2620d5e","claim":"Daniel Schneeberger resigned as Director at Anebulo Pharmaceuticals, Inc..","evidence_excerpt":"Daniel Schneeberger, M.D. resigned such positions in order to bring in Mr. Allen.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222000406/0001493152-22-000406-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"efb48126b1","claim":"Simon Allen was appointed as Chief Executive Officer at Anebulo Pharmaceuticals, Inc..","evidence_excerpt":"On January 3, 2022, Simon Allen was appointed to be our Chief Executive Officer and elected a member of our Board of Directors, both to be effective on February 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315222000406/0001493152-22-000406-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}